Skip to content
Trend Digital Magazine

Providing Stem Cells in Utero to Babies with Spina Bifida Enhances Life Outcomes, Research Shows

An innovative clinical study has discovered that delivering regenerative cells to unborn babies affected by spina bifida while undergoing fetal surgery could constitute a "important advancement" in treating birth defects.

Trial Details and Safety

The US-based trial focused on six developing infants with the 'open' form of spina bifida. Surgeons applied mother's placental stem cells directly onto the baby's spinal cord during the repair procedure.

Importantly, the cell therapy proved to be secure. The study team reported that the cells did not cause neoplasms, interfere with wound healing, or impede the resolution of associated brain abnormalities.

Positive Developments

Imaging conducted after delivery indicated a complete reversal of Chiari malformation in all six infants. This neurological improvement is strongly associated with enhanced physical outcomes.

"In the event it allows a greater number of infants able to walk who otherwise would not, it could establish itself as their standard of care," said the lead researcher. "These findings are extremely promising and pave the way for numerous possible novel therapies."

Future Implications and Hope

Commentators reviewing the findings proposed that further confirmation of these apparent benefits could signal a "new era" in prenatal intervention. The potential to improve neural deficits present before birth is considered a revolutionary objective.

Particularly welcome would be better management of continence and digestive health, which are frequent complications for people affected by this disorder.

Looking Ahead

Despite this being a first-in-human effort was small in scale, its safety demonstration and positive signals offer a robust platform for expanded clinical research. The combination of regenerative medicine with proven prenatal surgical methods holds considerable promise for changing life trajectories for future generations with this neural tube defect.

About the author

Charles Acosta

A digital strategist with over a decade of experience in tech journalism, focusing on emerging trends and startup ecosystems across Europe.

Trend Digital Magazine

Type to search articles.